Volume 53, Issue 5, Pages (May 2008)

Slides:

Advertisements

Similar presentations

Surgical Management of Prostate Cancer

Advertisements

Volume 61, Issue 5, Pages (May 2012)

Volume 68, Issue 6, Pages (December 2015)

Volume 56, Issue 5, Pages (November 2009)

Volume 187, Issue 6, Pages (June 2012)

The PSA Era is not Over for Prostate Cancer

Volume 68, Issue 2, Pages (August 2015)

Volume 50, Issue 1, Pages (July 2006)

Volume 69, Issue 3, Pages (March 2016)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 44, Issue 6, Pages (December 2003)

Volume 65, Issue 3, Pages (March 2014)

Volume 49, Issue 2, Pages (February 2006)

Volume 46, Issue 3, Pages (September 2004)

Volume 73, Issue 6, Pages (June 2018)

Volume 53, Issue 5, Pages (May 2008)

Volume 69, Issue 1, Pages (January 2016)

Volume 52, Issue 1, Pages (July 2007)

Volume 51, Issue 4, Pages (April 2007)

Volume 199, Issue 4, Pages e131-e132 (April 2018)

Volume 73, Issue 1, Pages (January 2018)

Volume 70, Issue 4, Pages (October 2016)

Volume 60, Issue 6, Pages (December 2011)

Volume 60, Issue 6, Pages (December 2011)

Volume 70, Issue 2, Pages (August 2016)

Volume 52, Issue 4, Pages (October 2007)

Volume 63, Issue 4, Pages e53-e56 (April 2013)

Volume 68, Issue 1, Pages (July 2015)

Nomograms for Bladder Cancer

Precystectomy Nomogram for Prediction of Advanced Bladder Cancer Stage

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 67, Issue 2, Pages (February 2015)

Volume 68, Issue 5, Pages (November 2015)

Volume 54, Issue 4, Pages (October 2008)

Volume 68, Issue 5, Pages (November 2015)

Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka

Volume 53, Issue 4, Pages (April 2008)

Volume 65, Issue 3, Pages (March 2014)

Volume 67, Issue 3, Pages (March 2015)

Volume 71, Issue 5, Pages (May 2017)

Volume 53, Issue 4, Pages (April 2008)

The PSA Era is not Over for Prostate Cancer

Volume 53, Issue 2, Pages (February 2008)

Volume 61, Issue 5, Pages (May 2012)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 68, Issue 6, Pages (December 2015)

Volume 66, Issue 6, Pages (December 2014)

Volume 61, Issue 2, Pages (February 2012)

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

The Inside-Out Transobturator Male Sling for the Surgical Treatment of Stress Urinary Incontinence After Radical Prostatectomy: Midterm Results of a Single-Center.

Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study Stephen H. Culp, Paul.

Volume 70, Issue 2, Pages (August 2016)

Volume 50, Issue 5, Pages (November 2006)

Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G

Prostate Cancer Nomograms: An Update

Testicular Cancer Variations in Time and Space in Europe

Volume 74, Issue 4, Pages (October 2018)

European Urology is “Your” Journal

Volume 74, Issue 6, Pages (December 2018)

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Volume 54, Issue 2, Pages (August 2008)

Volume 54, Issue 1, Pages (July 2008)

The Comparability of Models for Predicting the Risk of a Positive Prostate Biopsy with Prostate-Specific Antigen Alone: A Systematic Review Fritz Schröder,

Volume 68, Issue 2, Pages (August 2015)

Volume 53, Issue 2, Pages (February 2008)

Fernando P. Secin, Fernando J. Bianco, Nicholas T

European Urology Oncology

Oncoforum Urology: Prostate Cancer 2008 at a Glance

Volume 51, Issue 5, Pages (May 2007)

Esophagectomy for T1 Esophageal Cancer: Outcomes in 100 Patients and Implications for Endoscopic Therapy Arjun Pennathur, MD, Andrew Farkas, BA, Alyssa.

Presentation transcript:

Volume 53, Issue 5, Pages 960-966 (May 2008) Effects of Pathologic Stage on the Learning Curve for Radical Prostatectomy: Evidence That Recurrence in Organ-Confined Cancer Is Largely Related to Inadequate Surgical Technique Andrew J. Vickers, Fernando J. Bianco, Mithat Gonen, Angel M. Cronin, James A. Eastham, Deborah Schrag, Eric A. Klein, Alwyn M. Reuther, Michael W. Kattan, J. Edson Pontes, Peter T. Scardino European Urology Volume 53, Issue 5, Pages 960-966 (May 2008) DOI: 10.1016/j.eururo.2008.01.005 Copyright © 2008 European Association of Urology Terms and Conditions

Fig. 1 The learning curve for cancer control after radical prostatectomy, stratified by presence of organ-confined disease. The graph illustrates the predicted probability of freedom of biochemical recurrence (BCR) at 5 yr with increasing surgeon experience. Probabilities are for a patient with typical cancer severity (mean PSA, pathological stage, and grade) within each group. Light lines, organ-confined disease; dark lines, locally advanced disease; dashed lines, 95% CIs. European Urology 2008 53, 960-966DOI: (10.1016/j.eururo.2008.01.005) Copyright © 2008 European Association of Urology Terms and Conditions

Fig. 2 Biochemical recurrence after radical prostatectomy. Analysis was restricted to patients with organ-confined disease treated by surgeons with at least 1000 prior surgeries. European Urology 2008 53, 960-966DOI: (10.1016/j.eururo.2008.01.005) Copyright © 2008 European Association of Urology Terms and Conditions

Fig. 3 Learning curve for cancer control after radical prostatectomy, stratified by presence of organ-confined disease, in patients treated after 1995 (sensitivity analysis). The graph illustrates the predicted probability of freedom of biochemical recurrence (BCR) at 5 yr with increasing surgeon experience. Probabilities are for a patient with typical cancer severity (mean PSA, pathological stage, and grade) within each group. Light lines, organ-confined disease; dark lines: locally advanced disease; dashed lines, 95% CIs. European Urology 2008 53, 960-966DOI: (10.1016/j.eururo.2008.01.005) Copyright © 2008 European Association of Urology Terms and Conditions